Kim Bo-Ram, Lee Yejin, Kim Soo Jin, Kim Hyuntae, Lee Jong Won, Lee Seunghwan, Lee Jongmin
Department of Rehabilitation Medicine, Konkuk University School of Medicine & Konkuk University Medical Center, Seoul, Korea.
Ann Rehabil Med. 2018 Feb;42(1):180-183. doi: 10.5535/arm.2018.42.1.180. Epub 2018 Feb 28.
Palatal myoclonus (PM) is a rare disease that may induce dysphagia. Since dysphagia related to PM is unique and is characterized by myoclonic movements of the involved muscles, specific treatments are needed for rehabilitation. However, no study has investigated the treatment effectiveness for this condition. Therefore, the aim of this case report was to describe the benefit of combining behavioral treatment with valproic acid administration in patients with dysphagia triggered by PM. The two cases were treated with combined treatment. The outcomes evaluated by videofluoroscopic swallowing studies before and after the treatment showed significant decreases in myoclonic movements and improved swallowing function. We conclude that the combined treatment was effective against dysphagia related to PM.
腭肌阵挛(PM)是一种可能导致吞咽困难的罕见疾病。由于与PM相关的吞咽困难具有独特性,其特征为受累肌肉的肌阵挛运动,因此康复需要特定的治疗方法。然而,尚无研究调查过针对这种情况的治疗效果。因此,本病例报告的目的是描述行为治疗与丙戊酸给药相结合对由PM引发吞咽困难患者的益处。这两个病例接受了联合治疗。治疗前后通过电视荧光吞咽造影检查评估的结果显示,肌阵挛运动显著减少,吞咽功能得到改善。我们得出结论,联合治疗对与PM相关的吞咽困难有效。